About this tool
The SCORing MAstocytosis (SCORMA) index measures how extensive and how active cutaneous mastocytosis is, so that the course of the disease and the response to treatment can be followed visit by visit. It was designed by a Dutch mastocytosis group on the same principles as SCORAD for eczema and is mostly used in children, in whom repeated blood tests are harder.
Type the percent of the body surface with lesions (each solitary mastocytoma counts as 1%, diffuse cutaneous mastocytosis as 100%), score one typical lesion from 0 to 3 for pigmentation or erythema, blisters, elevation and Darier's sign, and type five symptoms over the last 3 weeks from 0 to 10 (triggering factors, flushing, diarrhea, itch, local bone pain). Three more questions that are not part of the score (anaphylaxis, organomegaly or abnormal blood count, baseline tryptase) shape the next steps. A decimal comma is accepted; values outside the scale block the result.
The result gives SCORMA = A/5 + 5B + 2C/5 with each part shown, and what to do next: baseline tryptase and blood count, when to refer for possible systemic mastocytosis, when to prescribe an epinephrine autoinjector, trigger avoidance, telling anesthetists, and symptom treatment. No validated mild, moderate or severe bands exist, so the tool compares scores over time instead. Sources: Heide R, et al. Acta Derm Venereol 2001; Heide R, et al. Clin Exp Dermatol 2009; Lange M, et al. Int J Mol Sci 2021; Hartmann K, et al. J Allergy Clin Immunol 2016.
Common questions
How is the SCORMA index calculated?
A is the percent of skin involved (0–100), B the sum of four lesion items scored 0–3 (0–12), and C the sum of five symptoms scored 0–10 (0–50). Each part was scaled to 20 and lesion activity weighted 3 times, giving A/5 + 5B + 2C/5. The range is 5.2 to 100 in a child with lesions.
Is there a SCORMA cut-off for severe disease?
No. The authors did not publish severity bands and none have been validated. Use the score to follow one child over time, measured the same way each visit. Higher scores went with higher serum tryptase in the 2009 study.
Which children with mastocytosis need an epinephrine autoinjector?
Current pediatric recommendations suggest one for children with extensive skin involvement (especially diffuse cutaneous mastocytosis), a history of anaphylaxis or severe systemic symptoms, or a highly raised baseline tryptase. Anaphylaxis is uncommon in childhood mastocytosis and mostly occurs in children with very extensive skin disease.
When should a child with skin mastocytosis be checked for systemic disease?
When there is liver, spleen or lymph node enlargement, an abnormal blood count, or a baseline tryptase that stays very high (above 100 ng/mL) or keeps rising. Organomegaly is the most reliable clinical sign. A raised tryptase without organomegaly is common in infants with extensive skin lesions and usually falls with time.
What is Darier's sign?
Redness, swelling and itch (sometimes a blister) of a mastocytosis lesion within minutes of gently stroking it, from mast cell degranulation. Avoid repeated rubbing in children with extensive disease or large mastocytomas.